4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-423056
Chief Executive Officer sold 4,098 shares at $49.26 ($201,867)
- Chief Executive Officer acquired 8,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kulkarni Samarth · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-13 | Exercise or conversion : show line 1 in the form | +8,333 | 263,834 | D | ||
| 2026-10-14 | Sale : show line 2 in the form | −4,098 | $49.26 | $201,867 | 259,736 | D |
| Open-market sales · 4,098 sh · avg $49.26 · $201,867 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-13 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −8,333 | 0 | D |
Loading xslF345X06/ownership.xml…